IRIS: Intelligent Retinal Imaging Systems

08/29/2025

Diabetic retinopathy is the leading cause of blindness among working-age U.S. adults, yet it’s largely preventable. The challenge? Fewer than half of patients with diabetes receive their annual eye exam, and up to 70% never complete referrals.

Join Dr. Brett Bielory for an inside look at how AI-enabled retinal screening and referral automation can help close this gap. Whether you’re working in a global health system, an FQHC, or bringing care directly into patients’ homes, you can improve outcomes and strengthen quality scores.

Click the link below to save your spot!

📅 September 16, 2025
⏰ 12:00 PM - 1:00 PM CDT

08/06/2025

August is National Eye Exam Month, a reminder that regular screenings are essential to preventing vision loss.

Whether you're a global health system, an FQHC, or bringing care to patients in their homes, IRIS can help you provide retinal eye exams at the point of care to close care gaps and improve outcomes for patients with diabetes.

Together, we can make sight-saving care more accessible for all.

Reach out today to learn more: https://retinalscreenings.com/contact-us/

07/23/2025

Whether you're in primary care, an FQHC, or supporting patients at home, IRIS helps you close one of the most persistent care gaps: diabetic eye exams.

As the leading cause of blindness among U.S. working-age adults, diabetic retinopathy too often goes undetected, especially in underserved populations.

IRIS empowers you to bring this exam to the point of care to improve access, outcomes, and performance on key value-based care measures. Best of all, it integrates seamlessly into your existing workflow.

Ready to learn more? Contact us today for a demo!

https://retinalscreenings.com/contact-us/

07/18/2025

IRIS Educator Lauren Palmer shares a powerful, first-hand story that shows what happens when diabetic eye exams are delivered at the point of care.

See how partnering with IRIS can help you meet your clinical, quality, and financial goals while helping to end preventable blindness ⬇️

https://retinalscreenings.com/contact-us/

07/09/2025

What if your patients could experience the impact of vision loss before it’s too late?

The IRIS Vision Simulator illustrates the devastating effects of untreated diabetic retinopathy (DR) by providing a powerful, real-world perspective.

DR remains the leading cause of blindness among working-age adults in the U.S., but it doesn’t have to be.

IRIS helps you bring diabetic eye exams to the point of care to close gaps, address issues early, and protect your patients’ vision.

Explore the simulator below, then schedule a demo to learn how you can end preventable blindness with IRIS!

https://retinalscreenings.com/vision-simulator/

07/01/2025

Do you know your current compliance rate for the diabetic eye exam? 2025 is halfway over, but that doesn't mean it's too late to meet your goals!

IRIS empowers our clients to bring the diabetic eye exam to point of care, allowing you to close this crucial care gap and prevent vision loss in your patients.

Are you ready to boost your clinical, quality, and financial performance? Reach out to us today to learn more!

http://retinalscreenings.com/contact-us/

05/20/2025

Diabetes is the leading cause of blindness among working-age adults — but it doesn’t have to be.

With early detection and treatment, over 90% of vision loss from diabetic retinopathy can be prevented.

IRIS makes it easy to bring diabetic eye exams to your patients — no referrals, no extra appointments. Just better access, earlier detection, and healthier outcomes.

Join the growing number of organizations closing care gaps and saving sight. Contact us to learn more!

https://retinalscreenings.com/

05/15/2025

We’re halfway through — how are you helping protect your patients’ vision?

Established by the National Eye Institute, Healthy Vision Month is a reminder of the critical importance of regular eye exams, especially for people with diabetes.

Fewer than 50% of individuals with diabetes receive their recommended annual diabetic eye exam, even though diabetic retinopathy remains the leading cause of blindness among working-age adults in the U.S.

At IRIS, we provide a simple, affordable solution that brings retinal exams to the point of care, helping our partners close care gaps, detect disease earlier, and preserve sight.

Let’s work together to end preventable blindness. Ready to make an impact? Contact us today. ⬇️

https://retinalscreenings.com/contact-us/

04/28/2025

Closing care gaps is easy with IRIS! ✅

We empower you to bring diabetic eye exams to patients, helping you boost HEDIS and STAR ratings while elevating patient care.

Contact us today to discover how we can help you achieve your goals:

https://retinalscreenings.com/contact-us/

04/22/2025

What if your patients could see what it feels like to lose their vision?

The IRIS Vision Simulator puts clinicians and patients in the shoes of someone losing their sight, illustrating the real-world impact of untreated diabetic retinopathy (DR).

With DR as the leading cause of blindness among working age adults in the U.S., this is an unfortunate reality for far too many people.

The good news? IRIS has a proven solution to help you bring diabetic eye exams to point of care, empowering you to close gaps and address issues before it's too late.

Explore our simulator below, and then schedule a demo to see how you can end preventable blindness with IRIS!

https://retinalscreenings.com/vision-simulator/

03/24/2025

We’re heading to AMGA’s 2025 Annual Conference this week — come say hello!

Diabetic retinopathy is the leading cause of blindness in working age adults, but less than 50% of at-risk patients received their annual diabetic eye exam. With over 1.5M exams performed, IRIS has the expertise to help you close this crucial gap.

Stop by booth 506 to see how our seamless, point-of-care solution can help you improve patient outcomes while elevating clinical, quality, and financial performance.

Ready to transform patient care? Let's chat about it!

03/18/2025

Diabetic retinopathy is the leading cause of blindness in working-age adults in the United States, but it's largely preventable with early detection. Too often, patients miss their annual diabetic eye exam due to access barriers, putting their sight at risk.

IRIS helps our clients bring this crucial exam to the point of care with ease — helping close care gaps, boost quality metrics, and prevent vision loss before it's too late.

Let's make preventable blindness a thing of the past! Schedule a demo today: https://retinalscreenings.com/contact-us/



https://retinalscreenings.com/blog/what-is-diabetic-retinopathy/

What is diabetic retinopathy? Learn how diabetes can impact your vision, the signs to watch for, and why early detection is crucial. Discover how IRIS retinal screening solutions help prevent vision loss.